ELITechGroup is now a Bruker company. Read the press release here.

Choose your sales office

News

ELITechGroup

Filter

Open filter menu
Reset
Reset

Validation of our Amoebiasis kits published in Journal of Clinical Microbiology

ELITechGroup Microbiology is pleased to announce that a recent study published in the Journal of Clinical Microbiology (DOI: 10.1128/jcm.00179-25) confirms the strong performance of the serological assays ELI.H.A Amoeba and ELITex Bicolor Amoeba, designed for the diagnosis of Entamoeba histolytica for amoebiasis infections. This evaluation compared four commercial assays across…
READ MORE

ELITechGroup Announces Regulatory Approval of its Blood Borne Virus Panel in Japan

ELITechGroup’s blood-borne virus (BBV) panel received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) The ELITe BBV panel was launched in 2022 and comprises three quantitative IVD assays targeting Human Immunodeficiency virus-1 (HIV-1), Human Hepatitis B Virus (HBV), and Human Hepatitis C Virus (HCV) Turin, June 13, 2024: ELITechGroup…
READ MORE

ELITechGroup achieves a new CE-IVDR Certification

ELITechGroup continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories The newly obtained IVDR certificate will expedite the transition to IVDR for quantitative Class C infectious diseases assays The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR…
READ MORE

ELITechGroup Launches Second IVDR Certified Gastrointestinal Infection Assay: GI Parasitic PLUS ELITe MGB® Kit 

ELITechGroup launches their second kit of the Gastrointestinal infection assay panel targeting parasitic pathogens.  The ELITe MGB Gastrointestinal assays are IVDR-certified in combination with InGenius and BeGenius, fully automated samples-to-results instruments.  The company will shortly launch two more gastrointestinal assay infection panels targeting viral pathogens and Norovirus.   ELITechGroup announces the…
READ MORE

ELITechGroup launches CE-IVDR certified GI Bacterial PLUS ELITe MGB® Kit and expands in vitro diagnostic portfolio

ELITechGroup launches their first kit of the Gastrointestinal assay panel targeting bacterial pathogens. ELITechGroup is planning to launch three additional kits covering the full range of gastrointestinal infections within the next quarter. In a significant move towards advancing global diagnostic capabilities, ELITechGroup proudly announces the introduction of the GI Bacterial…
READ MORE

Redesigned enterovirus and parechovirus real-time PCR reagents

Enterovirus and parechovirus real-time PCR reagents Redesigned for PCR efficiency and biplex compatibility Bothell, WA, November 7, 2023 — ELITechGroup MDx LLC (EGMDx) announced availability of their redesigned enterovirus and parechovirus analyte specific reagents* (ASR). The ASRs are designed to be used in the development of real-time PCR assays and…
READ MORE

Honoring ELITechGroup’s Legacy: The MGB Stabilizer Revolution

In the world of molecular diagnostics, we often encounter groundbreaking innovations that deserve a tribute. Today, we pay homage to a pivotal moment in history—the invention of the MGB stabilizer, i.e., Minor Groove Binder stabilizer, by ELITechGroup MDx LLC (formerly known as Epoch Biosciences) in 1995. This unsung hero has…
READ MORE

ELITechGroup obtains new IVDR certificate for PCR assays

After the release of the first IVDR certificate at the beginning of the year ELITech Group continues to expand its portfolio of IVDR-certified PCR assays to support European diagnostic laboratories. The company is fully committed to delivering its entire portfolio of nearly 60 molecular assays as IVDR compliant by 2026…
READ MORE

ELIVERSE: the video teaser

https://www.elitechgroup.com/news/wp-content/uploads/sites/33/2023/04/Eliver-Teaser-1.1-1-1.mp4   ElitechGroup Mdx is pleased to announce that ELIVERSE will be launched in Europe in 2024. With its introduction, ELITechGroup will have launched three molecular sample-to-result platforms in 8 years. Read the press release here.
READ MORE

ELITechGroup Molecular inaugurates its new headquarter in Turin

Turin, 22nd December 2022 – ELITechGroup has inaugurated its new headquarters in Turin, becoming one of the largest molecular biology hubs in Europe. The inauguration was held on Friday 16th December in the presence of institutional figures, collaborators, and employees. At the ribbon cutting, Michela Favaro – Deputy Mayor of…
READ MORE

ELITe InGenius™ nominated for Scientists’ Choice Awards®!

  ELITe InGenius™ nominated for Scientists’ Choice Awards! Each year the Scientists’ Choice Awards® celebrates the laboratory products and manufacturers that make a difference to the industry. SelectScience began the Scientists’ Choice Awards® in 2007 to enable scientists to voice their opinions on the best laboratory products. Scientists are then…
READ MORE

ELITechGroup receives CE mark

ITALY, Torino, December 9th, 2021. ELITechGroup announced today that its SARS-CoV-2 Extended ELITe MGB® Kit reliably differentiates the SARS-CoV-2 Omicron (B.1.1.529) variant from other variants of concern. The in-silico analysis was confirmed by testing patient samples positive for different SARS-CoV-2 variants including Omicron. ELITechGroup is pleased to offer the SARS-CoV-2…
READ MORE

Our new Molecular MDR/MTB multiplex assay

Een high performance based on our MGB® technology: – MTB complex: M.tuberculosis, M.africanum, M.bovis, M.canetti, M.microti, M.caprae. – MGB resistence: Rifampicine en Izoniazide. – Ultra sensitive: 6CFU/ml! – Ready to use monoreagent. In combination with our RT-PCR Sample-to-Result ELITe InGenius the most flexible solution for the diagnosis of Tuberculosis. “
READ MORE

ELITechGroup soutient AIDES & La ligue contre le cancer

Puteaux, France, le 15 Avril 2022, (14h CEST) ELITechGroup, fabricant et distributeur d’équipements et de réactifs de diagnostic in vitro, a annoncé apporter son soutien en offrant une aide financière auprès de deux associations françaises : AIDES et La Ligue contre le canc ELITechGroup, acteur incontournable de la biologie moléculaire,…
READ MORE

ELITechGroup supports AIDES & La Ligue contre le cancer

Puteaux, France, April 28th, 2022 – ELITechGroup, manufacturer and distributor of in vitro diagnostic instruments and reagents, has announced its charitable contributions to two French associations: AIDES and La Ligue contre le cancer. ELITechGroup, a key player in molecular biology diagnostics and clinical chemistry, brings together the expertise of innovative…
READ MORE